LIVE

VanEck Medical Robotics and Bionic Engineering UCITS ETF

UCTCYBO

Tracks: MVIS® Global Bionic Healthcare ESG Index (MVBIONTR)

Compare →

AUM

USD 13M

nano

TER

0.55%

Currency

USD

Replication

Physical

Inception

2022-12-02

Dividend

Accumulating

Domicile

Ireland

Asset Class

Thematic

Classification

Asset ClassEquity
Management StyleSmart Beta / Factor
DistributionAccumulating
AUM TierNano (<$50M)
Geographic FocusGlobal
IndexMVIS&reg;&nbsp;Global Bionic Healthcare ESG Index (MVBIONTR)
Currency TreatmentUnhedged
ReplicationPhysical — Full Replication
Legal StructureUCITS
UCITS EligibleYes

Equity Details

StyleBlend
Sectors (GICS)
Health Care
Factor Tilts
Quality

As the global population ages, so does the demand for biologically-inspired systems that improve the quality of later life. VanEck&rsquo;s Bionic Engineering ETF tracks the performance of the portfolio of innovative companies delivering medical, dental or vision-related implants, bioprinting, prosthesis, or preservation of organs and tissue. Invest in companies at the forefront of improving quality of life for the world&rsquo;s ageing population Gain diversified exposure to companies involved in medical implants and bionic enhancements for chronic diseases and functional impairments Access companies earning at least half their revenues from bionic engineering-related industries Invest in an ETF that screens out companies that violate social norms, derive revenues from controversial weapons, or participate in fossil fuel sectors, nuclear power, civilian firearms or tobacco Risk: You may lose money up to the total loss of your investment due to the Main Risk Factors such as Equity Market Risk and Industry Concentration Risk described below in the KIID and in the sales prospectus. Outperformance not guaranteed.

as of 2026-08-08

Annual Returns

YearAnnual
2025+1.36%
2024-0.86%
2023+4.60%